+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Velmetia"

Velmetia - API Insight, 2022 - Product Thumbnail Image

Velmetia - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Velmetia- Drug Insight, 2019 - Product Thumbnail Image

Velmetia- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Velmetia is a market of endocrine and metabolic disorder drugs. It is a class of drugs used to treat a variety of conditions, including diabetes, obesity, and thyroid disorders. These drugs are used to regulate hormones, enzymes, and other substances in the body. They can also be used to treat conditions such as osteoporosis, polycystic ovary syndrome, and adrenal insufficiency. Velmetia drugs are typically prescribed by endocrinologists and other healthcare professionals. Velmetia drugs are available in both generic and brand-name forms. Commonly prescribed Velmetia drugs include insulin, metformin, and levothyroxine. These drugs are available in various forms, such as tablets, capsules, and injections. Some of the companies in the Velmetia market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies produce a variety of Velmetia drugs, including insulin, metformin, and levothyroxine. Show Less Read more